Graham Cooper
DirectoratBeam Therapeutics· In proxies 2023–2025
Graham Cooper sits on 2 public boards.
Boards1
- Beam TherapeuticsDirector · 6 yr on the boardIndependentAudit (Chair)—Paid as an executive
'%20d='M450.888,318.933h6.906v.949h-2.9v7.592H453.84v-7.592h-2.953Zm15.185,3.691h-4.9v-3.691h-1.054v8.541h1.054v-3.849h4.9v3.849h1.054v-8.541h-1.054Zm5.431,1h4.745v-1H471.5v-2.689h4.956v-1h-6.01v8.594h6.221v-1H471.5Zm12.285.686,2.794,3.163h-1.318l-2.689-3.058H480.52v3.058h-1.055v-8.541h3.9a2.671,2.671,0,0,1,2.9,2.742A2.462,2.462,0,0,1,483.789,324.311Zm-.527-.79a1.727,1.727,0,0,0,1.845-1.793,1.753,1.753,0,0,0-1.845-1.793h-2.795v3.585Zm9.965-4.587,3.848,8.541h-1.16l-.843-1.9h-4.9l-.844,1.9h-1.16l3.849-8.541Zm1.476,5.694-2.057-4.588-2,4.588Zm8.647.105H500.5v2.742h-1.055v-8.541h3.9A2.9,2.9,0,1,1,503.349,324.733Zm0-4.8H500.5v3.8h2.847A1.9,1.9,0,0,0,503.349,319.936Zm6.538,3.69h4.745v-1h-4.745v-2.689h4.956v-1h-6.011v8.594h6.222v-1h-5.167Zm13.813.475a2.455,2.455,0,1,1-4.9,0v-5.115h-1.054V324.1a3.481,3.481,0,1,0,6.96,0v-5.115h-1Zm3.27-4.218h2.953v7.592h1.054v-7.592h2.9v-.949H526.97Zm9.28,7.592H537.3v-8.541H536.25Zm8.277-.844a3.2,3.2,0,0,1-3.374-3.374,3.161,3.161,0,0,1,3.374-3.427,3.393,3.393,0,0,1,2.372.949l.738-.686a4.343,4.343,0,0,0-3.11-1.265,4.227,4.227,0,0,0-4.429,4.428,4.158,4.158,0,0,0,4.429,4.377,4.465,4.465,0,0,0,3.164-1.265l-.738-.738A3.346,3.346,0,0,1,544.527,326.63Zm8.7-4.007c-1.266-.211-2.32-.474-2.32-1.423,0-1.055,1.16-1.476,2.267-1.476a2.761,2.761,0,0,1,2.32,1l.791-.474a3.344,3.344,0,0,0-3.217-1.53c-1.476,0-3.269.58-3.269,2.373,0,1.74,1.635,2.109,3.269,2.372,1.318.211,2.479.527,2.479,1.582,0,1.266-1.371,1.582-2.426,1.582a3.067,3.067,0,0,1-2.742-1.476l-.9.527a3.7,3.7,0,0,0,3.639,2c1.634,0,3.48-.633,3.48-2.531S554.914,322.887,553.227,322.623Zm-90.16-9.121h-12.18V285.611h12.18c5.062,0,9.333,2.531,9.333,7.8a6.1,6.1,0,0,1-4.114,5.747,6.942,6.942,0,0,1,5.01,6.643C473.3,311.71,468.34,313.5,463.068,313.5Zm-8.7-15.923h8.858c3.322,0,5.747-1.212,5.747-4.112,0-3.11-2.531-4.692-5.905-4.692h-8.7Zm0,12.6h8.7c2.9,0,6.749-.738,6.749-4.534-.053-3.48-3.585-4.956-6.591-4.956h-8.858Zm32.426,3.638c-6.063,0-10.334-4.007-10.334-10.281a9.833,9.833,0,0,1,10.176-10.176c6.011,0,10.6,3.691,9.807,11.547H479.729c.369,3.638,3.321,5.905,7.117,5.905,2.215,0,4.956-.9,6.222-2.479l2.215,2C493.279,312.711,489.851,313.819,486.793,313.819Zm-7.012-11.652,13.6.053c-.159-3.8-2.794-5.905-6.643-5.905A6.7,6.7,0,0,0,479.781,302.167Zm40.6,11.336h-3.163l-.052.053-.105-3.585a8.3,8.3,0,0,1-7.223,3.955c-5.642,0-10.071-3.9-10.071-10.282s4.481-10.176,10.123-10.123a8.247,8.247,0,0,1,7.276,3.9l.052-3.585h3.163Zm-10.386-16.924a7.2,7.2,0,0,0,0,14.394C519.483,310.972,519.483,296.578,509.993,296.578Zm43.34,5.694V313.45H556.6V302.219c0-5.378-3.11-8.752-8.277-8.752a7.315,7.315,0,0,0-6.908,4.271c-1.107-3.111-3.9-4.271-6.59-4.271a6.3,6.3,0,0,0-5.8,3.217l-.211-2.847H525.81L525.7,313.45h3.269V302.325c0-3.216,2.109-5.747,5.325-5.747,3.268,0,5.273,2.531,5.273,5.747V313.45h3.269V302.325c0-3.216,2.161-5.747,5.378-5.747C551.488,296.578,553.333,299.056,553.333,302.272ZM450.308,269.056a25.12,25.12,0,0,0-3.48,1.371l4.534,6.221Zm-14.5,10.6,7.012,3.27-4.587-6.169A32.115,32.115,0,0,0,435.808,279.653Zm1.423-7.54,10.809,8.911-5.273-12.917A52.977,52.977,0,0,0,437.232,272.113Zm48.93,13.6a25.049,25.049,0,0,0-1.634-3.374l-5.958,4.9ZM431.274,289.3a29.46,29.46,0,0,0-.738,3.744l7.8-.475Zm2.689-6.7a28.869,28.869,0,0,0-1.635,3.427l7.645,1.424Zm40.6-10.6-2.794,7.118,5.853-4.956A24.584,24.584,0,0,0,474.561,272.008Zm-17.135-4.323c-1.266.106-2.479.263-3.691.475l2.794,7.117ZM467.971,269l-.949,7.592,4.429-6.222A19.889,19.889,0,0,0,467.971,269Zm-37.646,27.522a30.9,30.9,0,0,0,.211,3.849l7.487-2.479Zm52.251-17.083a30.79,30.79,0,0,0-2.426-2.9l-4.481,6.222Zm-51.355,24.306a30.261,30.261,0,0,0,1.213,3.691l6.643-4.27ZM464.6,268.16c-.633-.105-1.213-.212-1.846-.264s-1.265-.105-1.845-.158l.949,7.539Zm-28.63,45.607,5.378-5.8-7.486,2.531A26.612,26.612,0,0,0,435.966,313.766Z'%20transform='translate(-430.325%20-267.685)'%20fill='%23fff'/%3e%3c/g%3e%3c/svg%3e)
Board seats come from each company's latest proxy statement.
Experience
- Beam TherapeuticsPublic company · 3 yr
- Director2023 – Present · 3 yrStock in role -24%
- Annual MeetingPublic company
- Director? – PresentNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?